1. Home
  2. FWDI vs DNA Comparison

FWDI vs DNA Comparison

Compare FWDI & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Industries Inc.

FWDI

Forward Industries Inc.

N/A

Current Price

$4.14

Market Cap

423.2M

Sector

Industrials

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.12

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWDI
DNA
Founded
1961
2008
Country
United States
United States
Employees
60
485
Industry
Plastic Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
423.2M
455.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FWDI
DNA
Price
$4.14
$8.12
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
1.0M
1.3M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$407.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.62
$5.37
52 Week High
$9.28
$17.58

Technical Indicators

Market Signals
Indicator
FWDI
DNA
Relative Strength Index (RSI) 44.24 45.41
Support Level $4.09 $7.59
Resistance Level $5.04 $10.21
Average True Range (ATR) 0.32 0.74
MACD -0.07 -0.07
Stochastic Oscillator 35.21 28.13

Price Performance

Historical Comparison
FWDI
DNA

About FWDI Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company operates in two segments: design and digital assets. The design segment consists of two operating segments (IPS and Kablooe, which have been aggregated into one reportable segment) that provide a full spectrum of hardware and software product design and engineering services to customers predominantly.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: